Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections

Clinical trial NCT00752219 · COMPLETED

Trial details

NCT number: NCT00752219
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Complicated Intra-abdominal Infections

Start date: 2009-03-31
Primary completion: 2009-11-30
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.